MUM1 Expression versus Hans Algorithm to Predict Prognosis in Indonesian Diffuse Large B-Cell Lymphoma Patients Receiving R-CHOP

BACKGROUND: Treatment response in diffuse large B-cell lymphoma (DLBCL) is heterogenous. The Hans algorithm (using 30% cut-offs for CD10, BCL6, and MUM1 protein expression) has been the most favored method to categorize DLBCL into germinal center B-cell (GCB) and non-GCB subtypes in order to predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Irawan, Cosphiadi, Iskandar, Martha, Harahap, Agnes Stephanie, Rumende, Cleopas Martin, Ham, Maria Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898019/
https://www.ncbi.nlm.nih.gov/pubmed/35256863
http://dx.doi.org/10.2147/CMAR.S345745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898019/
https://www.ncbi.nlm.nih.gov/pubmed/35256863
http://dx.doi.org/10.2147/CMAR.S345745

Ejemplares similares